1. Company Overview
Hindusthan Engineering & Industries Limited (HEIL) is the flagship engineering company of the Hindusthan Group, with a history spanning several decades. The company operates across railway rolling stock, railway track materials, steel foundry products, gas-based chemicals and jute products.
HEIL’s headquarters are in Kolkata, West Bengal. The company supplies critical railway components to the Ministry of Railways and also serves industrial and international customers.
According to its official website, HEIL specialises in Rolling Stock, Railway Track Materials, Gas-based Chemicals and Jute Products, and operates an ISO-accredited private-sector steel foundry.
2. Business Segments
Railway Rolling Stock
Railway products are the company’s largest business.
HEIL manufactures:
- Freight wagons
- Covered wagons
- Flat wagons
- Hopper wagons
- Tank wagons
- Bogies
- Couplers
- Draft gears
- Side frames
- Bolsters
- Other railway components
The company has a certified capacity of around 8,400 wagons per annum, according to CRISIL.
FY26 revenue from railway rolling stock was approximately ₹2,052 crore, compared with ₹2,327 crore in FY25.
Railway Track Materials
HEIL also manufactures railway track components including points and crossings/CMS crossings.
FY26 revenue from points and crossings increased to approximately ₹91 crore from ₹41 crore in FY25, according to the latest FY26 analysis.
Steel Foundry
The company operates a large private-sector steel foundry producing:
- Railway bogies
- Couplers
- Draft gears
- Side frames
- Bolsters
- Track components
- Industrial castings
The company has also developed specialised components such as anode yokes for aluminium smelters.
Chemicals
HEIL manufactures gas-based chemicals including sodium cyanide and rubber-chemical intermediates.
CRISIL states that HEIL has a sodium cyanide production capacity of approximately 6,372 MTPA, representing more than 30% domestic market share.
The chemical business supplies products used in industries including:
- Gold & silver refining
- Mining
- Electroplating
- Pharmaceuticals
- Rubber & tyres
- Heat treatment
Jute
Through its jute business, HEIL manufactures jute products used in packaging applications for:
- Food grains
- Sugar
- Cement
- Fertiliser
- Tea
FY26 jute revenue was approximately ₹400 crore, up from around ₹318 crore in FY25.
3. Manufacturing Footprint
HEIL operates multiple manufacturing facilities across West Bengal and Gujarat, including:
- Tiljala Plant – Kolkata
- Bamunari Plant – Hooghly
- Santragachi Plant – Howrah
- Chemicals Plant – Olpad, Gujarat
- Jute Plant – Champdany, West Bengal
The company’s official website provides details of these facilities.
4. Financial Performance
Consolidated/Reported FY26 Snapshot
| Particulars | FY25 | FY26 | Change |
|---|---|---|---|
| Revenue | ₹2,950 Cr | ₹2,747 Cr | -6.9% |
| EBITDA | ₹333 Cr | ₹275 Cr* | Decline |
| PAT | ₹218 Cr | ₹172 Cr* | -21.2% |
| EPS | ₹148.46 | ₹116.98 | -21.2% |
*Figures can differ depending on whether standalone/consolidated and accounting adjustments are considered. Latest FY26 analysis based on the annual report reports revenue of ₹2,747 crore and PAT of approximately ₹172 crore.
The key point is that FY26 was a weaker year financially, with revenue declining around 7% while profit declined more sharply.
The main pressure came from lower railway wagon revenue and operating deleverage.
5. FY26 Segment Performance
| Segment | FY26 Revenue | FY25 Revenue | YoY Change |
|---|---|---|---|
| Engineering – Wagons & Track | ₹2,161 Cr | ₹2,441 Cr | -11.5% |
| Jute | ₹401 Cr | ₹319 Cr | +25.5% |
| Chemicals | ₹186 Cr | ₹190 Cr | -2.2% |
The engineering division remains the dominant revenue contributor, while chemicals provide relatively higher-margin diversification.
6. Why Railway Demand Matters
Indian Railways has been increasing its focus on freight infrastructure, wagon availability and railway network capacity.
HEIL’s established presence in freight wagons and track components gives it exposure to this long-term infrastructure theme.
However, wagon manufacturing is also dependent on government procurement cycles, order execution, steel prices, component availability and railway spending.
CRISIL has highlighted HEIL’s established market position and strong order inflows in engineering products as key business strengths.
7. Export Business
HEIL historically exported railway components, castings and chemicals to markets including South Korea, Australia, North America and Europe.
However, the latest FY26 data indicates a significant reduction in exports, with exports falling from approximately ₹216 crore to around ₹20 crore. This means the company is currently far more dependent on the domestic market than in previous years.
This is an important factor for investors to monitor.
8. Shareholding
HEIL has a high promoter ownership structure, with promoter-group holdings reported at approximately 84%.
The company has approximately 1.47 crore equity shares outstanding.
| Particular | Details |
|---|---|
| Company | Hindusthan Engineering & Industries Ltd |
| ISIN | INE665C01026 |
| Face Value | ₹10 |
| Equity Shares | ~1.47 Crore |
| Status | Unlisted |
| RTA | C.B. Management Services |
| Promoter Holding | ~84% |
The high promoter ownership also means that any future listing would require substantial dilution to create the required public float.
9. Current Unlisted Share Price
As of September 2026, Moneycontrol shows an indicative price of approximately ₹1,025 per share.
Reported valuation metrics include:
- EPS: ~₹116
- P/E: ~6.47x
- P/B: ~0.88x
- P/S: ~0.47x
- 52-week high: ~₹1,310
- 52-week low: ~₹970
These are private-market/unlisted indications and not exchange-traded prices. Actual transaction prices can vary depending on buyer, seller, quantity and liquidity.
Moneycontrol – Hindusthan Engineering Unlisted Share Data
10. Valuation Perspective
At approximately ₹1,025 per share, the company is trading at a relatively modest earnings multiple based on the reported FY26 EPS.
However, the valuation should not be viewed only through the P/E ratio.
Investors should also examine:
- Quality and visibility of the railway order book
- Wagon production volumes
- Working-capital requirements
- Promoter-related balances
- Capital allocation
- Debt and short-term borrowings
- Sustainability of FY26 earnings
- Potential liquidity/exit route
For an unlisted company, valuation and liquidity are equally important considerations.
11. Key Growth Drivers
🚆 Railway Infrastructure
Continued investment in Indian Railways and freight transportation can support demand for wagons and railway components.
🏭 Established Manufacturing Base
HEIL has decades of engineering experience and multiple manufacturing facilities.
⚙️ Integrated Foundry Capabilities
Its foundry capabilities allow it to manufacture several critical railway and industrial components internally.
🧪 Chemical Diversification
The chemical division provides exposure to mining, refining, rubber and other industrial applications.
📦 Jute Business
Growing demand for sustainable packaging can provide a long-term opportunity for jute products.
🇮🇳 Domestic Infrastructure Opportunity
With exports currently representing a much smaller portion of business, domestic infrastructure and railway spending have become increasingly important growth drivers.
12. Key Risks
Railway Concentration
A large portion of revenue comes from railway rolling stock. Any slowdown in wagon procurement can materially affect revenue.
Margin Pressure
FY26 demonstrated that a relatively small decline in revenue can result in a much larger decline in profit because of operating leverage.
Raw Material Costs
Steel is a major input for wagon manufacturing. Significant fluctuations in steel prices can affect margins.
Working Capital
Large engineering projects and railway orders can require substantial working capital.
Export Decline
The sharp fall in exports during FY26 highlights the company’s changing geographic revenue mix.
Promoter Concentration
Promoters hold approximately 84%, resulting in limited public ownership.
Unlisted Liquidity
There is no continuous NSE/BSE trading market. An investor may have to wait for a suitable buyer to exit.
Corporate Governance / Financial Structure
Recent FY26 analysis has highlighted qualified audit observations and certain long-standing related-party balances. These should be examined carefully in the latest annual report before making an investment decision.
13. IPO / Listing Status
HEIL remains unlisted.
Despite various market platforms describing it as a potential pre-IPO opportunity, the latest FY26 analysis notes that the company’s annual report does not disclose a current IPO/listing plan.
Therefore, investors should not assume that an IPO is imminent merely because the shares are actively traded in the unlisted market.
14. Investment Snapshot
| Factor | Observation |
|---|---|
| Business | Railway engineering + chemicals + jute |
| Largest Segment | Railway wagons & engineering |
| Railway Capacity | ~8,400 wagons/year |
| FY26 Revenue | ~₹2,747 Cr |
| FY26 PAT | ~₹172 Cr |
| Current Indicative Price | ~₹1,025 |
| P/E | ~6.5x |
| P/B | ~0.9x |
| Promoter Holding | ~84% |
| Status | Unlisted |
| IPO | No confirmed current IPO plan |
| Major Opportunity | Indian railway & freight infrastructure |
| Major Risk | Railway concentration + unlisted liquidity |
15. UnlistedCart Takeaway
Hindusthan Engineering & Industries Limited is a diversified industrial company with a significant presence in railway wagons and track components, supported by chemical and jute businesses.
The company offers exposure to India’s railway and infrastructure ecosystem through an established manufacturing platform. At the same time, investors should closely monitor FY26 earnings decline, railway order visibility, working capital, promoter-related balances, capital allocation and the absence of a confirmed IPO plan.
For an unlisted investor, the purchase price, holding period and potential exit route are important alongside the underlying business fundamentals.
HEIL Manufacturing Facilities
Moneycontrol – Unlisted Share Information
Disclaimer: This report is prepared for informational and educational purposes only and should not be considered investment advice or a recommendation to buy or sell securities. Unlisted shares carry liquidity, valuation, business and execution risks. Indicative unlisted prices can vary between transactions. Investors should conduct their own due diligence and consult a SEBI-registered investment professional where appropriate.
For more such unlisted stocks visit https://unlistedcart.com/unlisted-shares/
